{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T10:33:17Z","timestamp":1794738797068,"version":"4.9.1"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic headache is particularly prevalent in migraineurs and it can progress to a condition known as medication overuse headache (MOH). MOH is a secondary headache caused by overuse of analgesics or other medications such as triptans to abort acute migraine attacks. The worsening of headache symptoms associated with medication overuse (MO) generally ameliorates following interruption of regular medication use, although the primary headache symptoms remain unaffected. MO patients may also develop certain behaviors such as ritualized drug administration, psychological drug attachment, and withdrawal symptoms that have been suggested to correlate with drug addiction. Although several reviews have been performed on this topic, to the authors best knowledge none of them have examined this topic from the addiction point of view. Therefore, we aimed to identify features in MO and drug addiction that may correlate. We initiate the review by introducing the classes of analgesics and medications that can cause MOH and those with high risk to produce MO. We further compare differences between sensitization resulting from MO and from drug addiction, the neuronal pathways that may be involved, and the genetic susceptibility that may overlap between the two conditions. Finally, ICHD recommendations to treat MOH will be provided herein.<\/jats:p>","DOI":"10.1186\/s10194-021-01224-8","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T05:03:58Z","timestamp":1619586238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Medication overuse and drug addiction: a narrative review from addiction perspective"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7344-5487","authenticated-orcid":false,"given":"Tatiane Teru","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Ornello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Quatrosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Torrente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Albanese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Vigneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Guglielmetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Maria De Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Dutordoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Colangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Fuccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Di Lenola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Spuntarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pilati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Di Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Van Dycke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramla Abuukar","family":"Abdullahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Maassen van den Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Martelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the European Headache Federation School of Advanced Studies (EHF-SAS)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"issue":"11","key":"1224_CR1","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","volume":"17","author":"G.B.D.H","year":"2018","unstructured":"G.B.D.H (2018) Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: A systematic analysis for the global burden of disease study 2016. Lancet Neurol 17(11):954\u2013976. https:\/\/doi.org\/10.1016\/S1474-4422(18)30322-3","journal-title":"Lancet Neurol"},{"issue":"1","key":"1224_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s10194-020-01208-0","volume":"21","author":"TJ Steiner","year":"2020","unstructured":"Steiner TJ et al (2020) Migraine remains second among the world's causes of disability, and first among young women: findings from GBD2019. J Headache Pain 21(1):137. https:\/\/doi.org\/10.1186\/s10194-020-01208-0","journal-title":"J Headache Pain"},{"key":"1224_CR3","doi-asserted-by":"publisher","unstructured":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 2018. 38(1): p. 1\u2013211 DOI: https:\/\/doi.org\/10.1177\/0333102417738202","DOI":"10.1177\/0333102417738202"},{"issue":"8","key":"1224_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2016.93","volume":"12","author":"A May","year":"2016","unstructured":"May A, Schulte LH (2016) Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol 12(8):455\u2013464. https:\/\/doi.org\/10.1038\/nrneurol.2016.93","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"1224_CR5","first-page":"1401","volume":"15","author":"A Negro","year":"2011","unstructured":"Negro A, Rocchietti-March M, Fiorillo M, Martelletti P (2011) Chronic migraine: current concepts and ongoing treatments. Eur Rev Med Pharmacol Sci 15(12):1401\u20131420","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"1224_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1136\/practneurol-2018-002048","volume":"19","author":"BR Wakerley","year":"2019","unstructured":"Wakerley BR (2019) Medication-overuse headache. Pract Neurol 19(5):399\u2013403. https:\/\/doi.org\/10.1136\/practneurol-2018-002048","journal-title":"Pract Neurol"},{"issue":"Suppl 1","key":"1224_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10072-019-03812-8","volume":"40","author":"MB Russell","year":"2019","unstructured":"Russell MB (2019) Epidemiology and management of medication-overuse headache in the general population. Neurol Sci 40(Suppl 1):23\u201326. https:\/\/doi.org\/10.1007\/s10072-019-03812-8","journal-title":"Neurol Sci"},{"issue":"1","key":"1224_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s10194-017-0830-2","volume":"19","author":"P Martelletti","year":"2018","unstructured":"Martelletti P (2018) The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine. J Headache Pain 19(1):2. https:\/\/doi.org\/10.1186\/s10194-017-0830-2","journal-title":"J Headache Pain"},{"issue":"1","key":"1224_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s10194-018-0875-x","volume":"19","author":"N Vandenbussche","year":"2018","unstructured":"Vandenbussche N, Laterza D, Lisicki M, Lloyd J, Lupi C, Tischler H, Toom K, Vandervorst F, Quintana S, Paemeleire K, Katsarava Z (2018) Medication-overuse headache: a widely recognized entity amidst ongoing debate. J Headache Pain 19(1):50. https:\/\/doi.org\/10.1186\/s10194-018-0875-x","journal-title":"J Headache Pain"},{"issue":"10","key":"1224_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrneurol.2016.124","volume":"12","author":"HC Diener","year":"2016","unstructured":"Diener HC, Holle D, Solbach K, Gaul C (2016) Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol 12(10):575\u2013583. https:\/\/doi.org\/10.1038\/nrneurol.2016.124","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"1224_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.tips.2004.12.008","volume":"26","author":"P Calabresi","year":"2005","unstructured":"Calabresi P, Cupini LM (2005) Medication-overuse headache: similarities with drug addiction. Trends Pharmacol Sci 26(2):62\u201368. https:\/\/doi.org\/10.1016\/j.tips.2004.12.008","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"1224_CR12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s13311-017-0592-1","volume":"15","author":"JJY Ong","year":"2018","unstructured":"Ong JJY, De Felice M (2018) Migraine treatment: current acute medications and their potential mechanisms of action. Neurotherapeutics 15(2):274\u2013290. https:\/\/doi.org\/10.1007\/s13311-017-0592-1","journal-title":"Neurotherapeutics"},{"issue":"1\u20132","key":"1224_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pain.2005.03.008","volume":"115","author":"AH Ahn","year":"2005","unstructured":"Ahn AH, Basbaum AI (2005) Where do triptans act in the treatment of migraine? Pain 115(1\u20132):1\u20134. https:\/\/doi.org\/10.1016\/j.pain.2005.03.008","journal-title":"Pain"},{"issue":"Pt 1","key":"1224_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/brain\/123.1.9","volume":"123","author":"P Tfelt-Hansen","year":"2000","unstructured":"Tfelt-Hansen P et al (2000) Ergotamine in the acute treatment of migraine: a review and European consensus. Brain 123(Pt 1):9\u201318. https:\/\/doi.org\/10.1093\/brain\/123.1.9","journal-title":"Brain"},{"issue":"3","key":"1224_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14656566.2020.1828347","volume":"22","author":"P Tfelt-Hansen","year":"2020","unstructured":"Tfelt-Hansen P (2020) Pharmacological strategies to treat attacks of episodic migraine in adults. Expert Opin Pharmacother 22(3):1\u201312. https:\/\/doi.org\/10.1080\/14656566.2020.1828347","journal-title":"Expert Opin Pharmacother"},{"issue":"13","key":"1224_CR16","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1517\/14656566.2014.937704","volume":"15","author":"SD Silberstein","year":"2014","unstructured":"Silberstein SD, Stirpe JC (2014) COX inhibitors for the treatment of migraine. Expert Opin Pharmacother 15(13):1863\u20131874. https:\/\/doi.org\/10.1517\/14656566.2014.937704","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"1224_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1163\/156856003322699573","volume":"11","author":"GG Graham","year":"2003","unstructured":"Graham GG, Scott KF (2003) Mechanisms of action of paracetamol and related analgesics. Inflammopharmacology 11(4):401\u2013413. https:\/\/doi.org\/10.1163\/156856003322699573","journal-title":"Inflammopharmacology"},{"key":"1224_CR18","doi-asserted-by":"publisher","unstructured":"Inturrisi CE (2002) Clinical pharmacology of opioids for pain. Clin J Pain 18(4 Suppl):S3\u2013S13. https:\/\/doi.org\/10.1097\/00002508-200207001-00002","DOI":"10.1097\/00002508-200207001-00002"},{"issue":"2","key":"1224_CR19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1124\/pr.114.009209","volume":"68","author":"L Toll","year":"2016","unstructured":"Toll L, Bruchas MR, Calo' G, Cox BM, Zaveri NT (2016) Nociceptin\/Orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems. Pharmacol Rev 68(2):419\u2013457. https:\/\/doi.org\/10.1124\/pr.114.009209","journal-title":"Pharmacol Rev"},{"issue":"1","key":"1224_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11916-010-0155-1","volume":"15","author":"M De Felice","year":"2011","unstructured":"De Felice M, Ossipov MH, Porreca F (2011) Update on medication-overuse headache. Curr Pain Headache Rep 15(1):79\u201383. https:\/\/doi.org\/10.1007\/s11916-010-0155-1","journal-title":"Curr Pain Headache Rep"},{"issue":"7","key":"1224_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1212\/wnl.59.7.1011","volume":"59","author":"V Limmroth","year":"2002","unstructured":"Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC (2002) Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59(7):1011\u20131014. https:\/\/doi.org\/10.1212\/wnl.59.7.1011","journal-title":"Neurology"},{"issue":"4","key":"1224_CR22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(10)70008-9","volume":"9","author":"S Evers","year":"2010","unstructured":"Evers S, Marziniak M (2010) Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol 9(4):391\u2013401. https:\/\/doi.org\/10.1016\/S1474-4422(10)70008-9","journal-title":"Lancet Neurol"},{"issue":"3","key":"1224_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1468-2982.2009.01913.x","volume":"30","author":"AI Scher","year":"2010","unstructured":"Scher AI, Lipton RB, Stewart WF, Bigal M (2010) Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study. Cephalalgia 30(3):321\u2013328. https:\/\/doi.org\/10.1111\/j.1468-2982.2009.01913.x","journal-title":"Cephalalgia"},{"issue":"12","key":"1224_CR24","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2165\/00002018-200124120-00005","volume":"24","author":"Z Katsarava","year":"2001","unstructured":"Katsarava Z, Diener HC, Limmroth V (2001) Medication overuse headache: a focus on analgesics, ergot alkaloids and triptans. Drug Saf 24(12):921\u2013927. https:\/\/doi.org\/10.2165\/00002018-200124120-00005","journal-title":"Drug Saf"},{"issue":"1","key":"1224_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/187447370801150611184218","volume":"8","author":"J van Amsterdam","year":"2015","unstructured":"van Amsterdam J, van den Brink W (2015) The misuse of prescription opioids: a threat for Europe? Curr Drug Abuse Rev 8(1):3\u201314. https:\/\/doi.org\/10.2174\/187447370801150611184218","journal-title":"Curr Drug Abuse Rev"},{"issue":"6","key":"1224_CR26","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.drugpo.2014.07.009","volume":"25","author":"DF Weisberg","year":"2014","unstructured":"Weisberg DF, Becker WC, Fiellin DA, Stannard C (2014) Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons. Int J Drug Policy 25(6):1124\u20131130. https:\/\/doi.org\/10.1016\/j.drugpo.2014.07.009","journal-title":"Int J Drug Policy"},{"issue":"5","key":"1224_CR27","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1213\/ANE.0000000000002403","volume":"125","author":"CD Soelberg","year":"2017","unstructured":"Soelberg CD, Brown RE Jr, du Vivier D, Meyer JE, Ramachandran BK (2017) The US opioid crisis: current federal and state legal issues. Anesth Analg 125(5):1675\u20131681. https:\/\/doi.org\/10.1213\/ANE.0000000000002403","journal-title":"Anesth Analg"},{"issue":"10","key":"1224_CR28","doi-asserted-by":"publisher","first-page":"e498","DOI":"10.1016\/S2468-2667(19)30128-8","volume":"4","author":"GA Kalkman","year":"2019","unstructured":"Kalkman GA, Kramers C, van Dongen RT, van den Brink W, Schellekens A (2019) Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study. Lancet Public Health 4(10):e498\u2013e505. https:\/\/doi.org\/10.1016\/S2468-2667(19)30128-8","journal-title":"Lancet Public Health"},{"issue":"1","key":"1224_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s10194-018-0899-2","volume":"20","author":"TJ Steiner","year":"2019","unstructured":"Steiner TJ, Jensen R, Katsarava Z, Linde M, MacGregor EA, Osipova V, Paemeleire K, Olesen J, Peters M, Martelletti P (2019) Aids to management of headache disorders in primary care (2nd edition) : on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache. J Headache Pain 20(1):57. https:\/\/doi.org\/10.1186\/s10194-018-0899-2","journal-title":"J Headache Pain"},{"issue":"2","key":"1224_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s0376-8716(98)00151-3","volume":"54","author":"ML Van Etten","year":"1999","unstructured":"Van Etten ML, Anthony JC (1999) Comparative epidemiology of initial drug opportunities and transitions to first use: marijuana, cocaine, hallucinogens and heroin. Drug Alcohol Depend 54(2):117\u2013125. https:\/\/doi.org\/10.1016\/s0376-8716(98)00151-3","journal-title":"Drug Alcohol Depend"},{"key":"1224_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ypmed.2018.05.015","volume":"113","author":"RL DuPont","year":"2018","unstructured":"DuPont RL, Han B, Shea CL, Madras BK (2018) Drug use among youth: national survey data support a common liability of all drug use. Prev Med 113:68\u201373. https:\/\/doi.org\/10.1016\/j.ypmed.2018.05.015","journal-title":"Prev Med"},{"key":"1224_CR32","doi-asserted-by":"publisher","unstructured":"Delgado-Lobete, L., Montes-Montes R., Vila-Paz A., Cruz-Vali\u00f1o J.M., G\u00e1ndara-Gafo B., Talavera-Valverde M.\u00c1., Santos-del-Riego S., Individual and Environmental Factors Associated with Tobacco Smoking, Alcohol Abuse and Illegal Drug Consumption in University Students: A Mediating Analysis. Int J Environ Res Public Health, 2020. 17(9) DOI: https:\/\/doi.org\/10.3390\/ijerph17093019, 17, 9","DOI":"10.3390\/ijerph17093019"},{"issue":"1507","key":"1224_CR33","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1098\/rstb.2008.0093","volume":"363","author":"TE Robinson","year":"2008","unstructured":"Robinson TE, Berridge KC (2008) Review. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond Ser B Biol Sci 363(1507):3137\u20133146. https:\/\/doi.org\/10.1098\/rstb.2008.0093","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"1224_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fnbeh.2019.00129","volume":"13","author":"TT Takahashi","year":"2019","unstructured":"Takahashi TT, Vengeliene V, Enkel T, Reithofer S, Spanagel R (2019) Pavlovian to instrumental transfer responses do not correlate with addiction-like behavior in rats. Front Behav Neurosci 13:129. https:\/\/doi.org\/10.3389\/fnbeh.2019.00129","journal-title":"Front Behav Neurosci"},{"key":"1224_CR35","doi-asserted-by":"publisher","unstructured":"Association, A.P., Diagnostic and statistical manual of mental disorders, 5th Edition. 2013, DOI: https:\/\/doi.org\/10.1176\/appi.books.9780890425596","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"3","key":"1224_CR36","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/WCO.0000000000000687","volume":"32","author":"I de Boer","year":"2019","unstructured":"de Boer I, van den Maagdenberg A, Terwindt GM (2019) Advance in genetics of migraine. Curr Opin Neurol 32(3):413\u2013421. https:\/\/doi.org\/10.1097\/WCO.0000000000000687","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"1224_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s10194-019-1017-9","volume":"20","author":"HG Sutherland","year":"2019","unstructured":"Sutherland HG, Albury CL, Griffiths LR (2019) Advances in genetics of migraine. J Headache Pain 20(1):72. https:\/\/doi.org\/10.1186\/s10194-019-1017-9","journal-title":"J Headache Pain"},{"issue":"10","key":"1224_CR38","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.pain.2014.07.002","volume":"155","author":"ML Westergaard","year":"2014","unstructured":"Westergaard ML, Gl\u00fcmer C, Hansen EH, Jensen RH (2014) Prevalence of chronic headache with and without medication overuse: associations with socioeconomic position and physical and mental health status. Pain 155(10):2005\u20132013. https:\/\/doi.org\/10.1016\/j.pain.2014.07.002","journal-title":"Pain"},{"issue":"4","key":"1224_CR39","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10194-012-0432-y","volume":"13","author":"P Jonsson","year":"2012","unstructured":"Jonsson P, Linde M, Hensing G, Hedenrud T (2012) Sociodemographic differences in medication use, health-care contacts and sickness absence among individuals with medication-overuse headache. J Headache Pain 13(4):281\u2013290. https:\/\/doi.org\/10.1007\/s10194-012-0432-y","journal-title":"J Headache Pain"},{"issue":"1","key":"1224_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1526-4610.2005.05006.x","volume":"45","author":"HT Atasoy","year":"2005","unstructured":"Atasoy HT, Unal AE, Atasoy N, Emre U, Sumer M (2005) Low income and education levels may cause medication overuse and chronicity in migraine patients. Headache 45(1):25\u201331. https:\/\/doi.org\/10.1111\/j.1526-4610.2005.05006.x","journal-title":"Headache"},{"issue":"3","key":"1224_CR41","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ejpain.2004.07.006","volume":"9","author":"HT Atasoy","year":"2005","unstructured":"Atasoy HT, Atasoy N, Unal AE, Emre U, Sumer M (2005) Psychiatric comorbidity in medication overuse headache patients with pre-existing headache type of episodic tension-type headache. Eur J Pain 9(3):285\u2013291. https:\/\/doi.org\/10.1016\/j.ejpain.2004.07.006","journal-title":"Eur J Pain"},{"issue":"7","key":"1224_CR42","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1468-2982.2005.00910.x","volume":"25","author":"F Radat","year":"2005","unstructured":"Radat F, Creac'h C, Swendsen JD, Lafittau M, Irachabal S, Dousset V, Henry P (2005) Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 25(7):519\u2013522. https:\/\/doi.org\/10.1111\/j.1468-2982.2005.00910.x","journal-title":"Cephalalgia"},{"issue":"1","key":"1224_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1364-6613(97)01009-7","volume":"1","author":"B Everitt","year":"1997","unstructured":"Everitt B (1997) Craving cocaine cues: cognitive neuroscience meets drug addiction research. Trends Cogn Sci 1(1):1\u20132. https:\/\/doi.org\/10.1016\/S1364-6613(97)01009-7","journal-title":"Trends Cogn Sci"},{"issue":"11","key":"1224_CR44","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1093\/brain\/awt251","volume":"136","author":"MA Louter","year":"2013","unstructured":"Louter MA, Bosker JE, van Oosterhout WPJ, van Zwet EW, Zitman FG, Ferrari MD, Terwindt GM (2013) Cutaneous allodynia as a predictor of migraine chronification. Brain 136(11):3489\u20133496. https:\/\/doi.org\/10.1093\/brain\/awt251","journal-title":"Brain"},{"key":"1224_CR45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.brainresbull.2016.04.006","volume":"125","author":"R Camarini","year":"2016","unstructured":"Camarini R, Pautassi RM (2016) Behavioral sensitization to ethanol: neural basis and factors that influence its acquisition and expression. Brain Res Bull 125:53\u201378. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.04.006","journal-title":"Brain Res Bull"},{"issue":"9","key":"1224_CR46","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/0006-3223(95)00497-1","volume":"40","author":"SM Strakowski","year":"1996","unstructured":"Strakowski SM, Sax KW, Setters MJ, Keck PE Jr (1996) Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans. Biol Psychiatry 40(9):872\u2013880. https:\/\/doi.org\/10.1016\/0006-3223(95)00497-1","journal-title":"Biol Psychiatry"},{"issue":"5","key":"1224_CR47","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1111\/j.1471-4159.1988.tb03036.x","volume":"50","author":"PW Kalivas","year":"1988","unstructured":"Kalivas PW, Duffy P (1988) Effects of daily cocaine and morphine treatment on somatodendritic and terminal field dopamine release. J Neurochem 50(5):1498\u20131504. https:\/\/doi.org\/10.1111\/j.1471-4159.1988.tb03036.x","journal-title":"J Neurochem"},{"issue":"6","key":"1224_CR48","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1523\/jneurosci.09-06-02051.1989","volume":"9","author":"R Kuczenski","year":"1989","unstructured":"Kuczenski R, Segal D (1989) Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci 9(6):2051\u20132065. https:\/\/doi.org\/10.1523\/jneurosci.09-06-02051.1989","journal-title":"J Neurosci"},{"issue":"8","key":"1224_CR49","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.pnpbp.2007.08.027","volume":"31","author":"M Leyton","year":"2007","unstructured":"Leyton M (2007) Conditioned and sensitized responses to stimulant drugs in humans. Prog Neuro-Psychopharmacol Biol Psychiatry 31(8):1601\u20131613. https:\/\/doi.org\/10.1016\/j.pnpbp.2007.08.027","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1224_CR50","doi-asserted-by":"publisher","first-page":"104494","DOI":"10.1016\/j.neuint.2019.104494","volume":"129","author":"E Sugiyama","year":"2019","unstructured":"Sugiyama E, Kondo T, Kuzumaki N, Honda K, Yamanaka A, Narita M, Suematsu M, Sugiura Y (2019) Mechanical allodynia induced by optogenetic sensory nerve excitation activates dopamine signaling and metabolism in medial nucleus accumbens. Neurochem Int 129:104494. https:\/\/doi.org\/10.1016\/j.neuint.2019.104494","journal-title":"Neurochem Int"},{"issue":"17","key":"1224_CR51","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1212\/wnl.0000000000003861","volume":"88","author":"AF DaSilva","year":"2017","unstructured":"DaSilva AF, Nascimento TD, Jassar H, Heffernan J, Toback RL, Lucas S, DosSantos MF, Bellile EL, Boonstra PS, Taylor JMG, Casey KL, Koeppe RA, Smith YR, Zubieta JK (2017) Dopamine D2\/D3 imbalance during migraine attack and allodynia in vivo. Neurology 88(17):1634\u20131641. https:\/\/doi.org\/10.1212\/wnl.0000000000003861","journal-title":"Neurology"},{"issue":"1","key":"1224_CR52","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/wnl.49.1.201","volume":"49","author":"SJ Peroutka","year":"1997","unstructured":"Peroutka SJ, Wilhoit T, Jones K (1997) Clinical susceptibility to migraine with aura is modified by dopamine D<sub>2<\/sub> receptor (DRD2) <em>Nco<\/em> I alleles. Neurology 49(1):201\u2013206. https:\/\/doi.org\/10.1212\/wnl.49.1.201","journal-title":"Neurology"},{"issue":"3","key":"1224_CR53","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1046\/j.1468-2982.1994.014003235.x","volume":"14","author":"C W\u00f6ber","year":"1994","unstructured":"W\u00f6ber C, Br\u00fccke T, W\u00f6ber-Bing\u00f6l C, Asenbaum S, Wessely P, Podreka I (1994) Dopamine D2 receptor blockade and Antimigraine action of Flunarizine. Cephalalgia 14(3):235\u2013240. https:\/\/doi.org\/10.1046\/j.1468-2982.1994.014003235.x","journal-title":"Cephalalgia"},{"issue":"11","key":"1224_CR54","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/j.1468-2982.2007.01478.x","volume":"27","author":"S Akerman","year":"2007","unstructured":"Akerman S, Goadsby P (2007) Dopamine and migraine: biology and clinical implications. Cephalalgia 27(11):1308\u20131314. https:\/\/doi.org\/10.1111\/j.1468-2982.2007.01478.x","journal-title":"Cephalalgia"},{"issue":"27","key":"1224_CR55","doi-asserted-by":"publisher","first-page":"9957","DOI":"10.1523\/JNEUROSCI.4605-14.2015","volume":"35","author":"IK Martikainen","year":"2015","unstructured":"Martikainen IK, Nuechterlein EB, Pecina M, Love TM, Cummiford CM, Green CR, Stohler CS, Zubieta JK (2015) Chronic Back pain is associated with alterations in dopamine neurotransmission in the ventral striatum. J Neurosci 35(27):9957\u20139965. https:\/\/doi.org\/10.1523\/JNEUROSCI.4605-14.2015","journal-title":"J Neurosci"},{"issue":"11","key":"1224_CR56","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/nn1579","volume":"8","author":"BJ Everitt","year":"2005","unstructured":"Everitt BJ, Robbins TW (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8(11):1481\u20131489. https:\/\/doi.org\/10.1038\/nn1579","journal-title":"Nat Neurosci"},{"issue":"1","key":"1224_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-psych-122414-033457","volume":"67","author":"BJ Everitt","year":"2016","unstructured":"Everitt BJ, Robbins TW (2016) Drug addiction: updating actions to habits to compulsions ten years on. Annu Rev Psychol 67(1):23\u201350. https:\/\/doi.org\/10.1146\/annurev-psych-122414-033457","journal-title":"Annu Rev Psychol"},{"issue":"8","key":"1224_CR58","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1037\/amp0000059","volume":"71","author":"KC Berridge","year":"2016","unstructured":"Berridge KC, Robinson TE (2016) Liking, wanting, and the incentive-sensitization theory of addiction. Am Psychol 71(8):670\u2013679. https:\/\/doi.org\/10.1037\/amp0000059","journal-title":"Am Psychol"},{"issue":"10","key":"1224_CR59","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/35094560","volume":"2","author":"SE Hyman","year":"2001","unstructured":"Hyman SE, Malenka RC (2001) Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2(10):695\u2013703. https:\/\/doi.org\/10.1038\/35094560","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"1224_CR60","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1177\/0333102415593088","volume":"36","author":"C-C Chiang","year":"2016","unstructured":"Chiang C-C, Schwedt TJ, Wang SJ, Dodick DW (2016) Treatment of medication-overuse headache: a systematic review. Cephalalgia 36(4):371\u2013386. https:\/\/doi.org\/10.1177\/0333102415593088","journal-title":"Cephalalgia"},{"issue":"9","key":"1224_CR61","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S1474-4422(19)30146-2","volume":"18","author":"HC Diener","year":"2019","unstructured":"Diener HC, Dodick D, Evers S, Holle D, Jensen RH, Lipton RB, Porreca F, Silberstein S, Schwedt T (2019) Pathophysiology, prevention, and treatment of medication overuse headache. Lancet Neurol 18(9):891\u2013902. https:\/\/doi.org\/10.1016\/S1474-4422(19)30146-2","journal-title":"Lancet Neurol"},{"issue":"1","key":"1224_CR62","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/1520-6629(197401)2:1<85::AID-JCOP2290020130>3.0.CO;2-B","volume":"2","author":"WA Hunt","year":"1974","unstructured":"Hunt WA, Bespalec DA (1974) Relapse rates after treatment for heroin addiction. J Commun Psychol 2(1):85\u201387. https:\/\/doi.org\/10.1002\/1520-6629(197401)2:1<85::AID-JCOP2290020130>3.0.CO;2-B","journal-title":"J Commun Psychol"},{"issue":"1","key":"1224_CR63","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/1520-6629(197301)1:1<66::AID-JCOP2290010119>3.0.CO;2-R","volume":"1","author":"WA Hunt","year":"1973","unstructured":"Hunt WA, General WR (1973) Relapse rates after treatment for alcoholism. J Commun Psychol 1(1):66\u201368. https:\/\/doi.org\/10.1002\/1520-6629(197301)1:1<66::AID-JCOP2290010119>3.0.CO;2-R","journal-title":"J Commun Psychol"},{"issue":"1","key":"1224_CR64","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1468-2982.2004.00789.x","volume":"25","author":"Z Katsarava","year":"2005","unstructured":"Katsarava Z, Muessig M, Dzagnidze A, Fritsche G, Diener HC, Limmroth V (2005) Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 25(1):12\u201315. https:\/\/doi.org\/10.1111\/j.1468-2982.2004.00789.x","journal-title":"Cephalalgia"},{"issue":"1","key":"1224_CR65","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/head.12979","volume":"57","author":"A Raggi","year":"2017","unstructured":"Raggi A, Giovannetti AM, Leonardi M, Sansone E, Schiavolin S, Curone M, Grazzi L, Usai S, D'Amico D (2017) Predictors of 12-months relapse after withdrawal treatment in hospitalized patients with chronic migraine associated with medication overuse: a longitudinal observational study. Headache 57(1):60\u201370. https:\/\/doi.org\/10.1111\/head.12979","journal-title":"Headache"},{"issue":"11","key":"1224_CR66","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1111\/j.1468-2982.2008.01659.x","volume":"28","author":"P Rossi","year":"2008","unstructured":"Rossi P, Faroni J, Nappi G (2008) Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study. Cephalalgia 28(11):1196\u20131200. https:\/\/doi.org\/10.1111\/j.1468-2982.2008.01659.x","journal-title":"Cephalalgia"},{"issue":"1","key":"1224_CR67","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1152\/jn.00632.2015","volume":"115","author":"L Becerra","year":"2016","unstructured":"Becerra L, Bishop J, Barmettler G, Xie Y, Navratilova E, Porreca F, Borsook D (2016) Triptans disrupt brain networks and promote stress-induced CSD-like responses in cortical and subcortical areas. J Neurophysiol 115(1):208\u2013217. https:\/\/doi.org\/10.1152\/jn.00632.2015","journal-title":"J Neurophysiol"},{"issue":"3","key":"1224_CR68","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/WCO.0b013e328346af25","volume":"24","author":"M De Felice","year":"2011","unstructured":"De Felice M, Ossipov MH, Porreca F (2011) Persistent medication-induced neural adaptations, descending facilitation, and medication overuse headache. Curr Opin Neurol 24(3):193\u2013196. https:\/\/doi.org\/10.1097\/WCO.0b013e328346af25","journal-title":"Curr Opin Neurol"},{"issue":"Pt 8","key":"1224_CR69","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1093\/brain\/awq159","volume":"133","author":"M De Felice","year":"2010","unstructured":"De Felice M et al (2010) Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers. Brain 133(Pt 8):2475\u20132488. https:\/\/doi.org\/10.1093\/brain\/awq159","journal-title":"Brain"},{"issue":"2\u20133","key":"1224_CR70","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0304-3959(00)00478-4","volume":"89","author":"R Burstein","year":"2001","unstructured":"Burstein R (2001) Deconstructing migraine headache into peripheral and central sensitization. Pain 89(2\u20133):107\u2013110. https:\/\/doi.org\/10.1016\/s0304-3959(00)00478-4","journal-title":"Pain"},{"issue":"6609","key":"1224_CR71","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/384560a0","volume":"384","author":"AM Strassman","year":"1996","unstructured":"Strassman AM, Raymond SA, Burstein R (1996) Sensitization of meningeal sensory neurons and the origin of headaches. Nature 384(6609):560\u2013564. https:\/\/doi.org\/10.1038\/384560a0","journal-title":"Nature"},{"issue":"3","key":"1224_CR72","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/ana.21897","volume":"67","author":"M De Felice","year":"2010","unstructured":"De Felice M et al (2010) Triptan-induced latent sensitization: a possible basis for medication overuse headache. Ann Neurol 67(3):325\u2013337. https:\/\/doi.org\/10.1002\/ana.21897","journal-title":"Ann Neurol"},{"key":"1224_CR73","doi-asserted-by":"crossref","unstructured":"Gardell, L.R., et al., Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers. J Neurosci, 2002. 22(15): p. 6747\u20136755 DOI: 20026648","DOI":"10.1523\/JNEUROSCI.22-15-06747.2002"},{"issue":"1","key":"1224_CR74","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11916-011-0234-y","volume":"16","author":"S Bongsebandhu-phubhakdi","year":"2012","unstructured":"Bongsebandhu-phubhakdi S, Srikiatkhachorn A (2012) Pathophysiology of medication-overuse headache: implications from animal studies. Curr Pain Headache Rep 16(1):110\u2013115. https:\/\/doi.org\/10.1007\/s11916-011-0234-y","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"1224_CR75","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10194-008-0019-9","volume":"9","author":"I Ayzenberg","year":"2008","unstructured":"Ayzenberg I, Oberman M, Leineweber K, Franke L, Yoon MS, Diener HC, Katsarava Z (2008) Increased activity of serotonin uptake in platelets in medication overuse headache following regular intake of analgesics and triptans. J Headache Pain 9(2):109\u2013112. https:\/\/doi.org\/10.1007\/s10194-008-0019-9","journal-title":"J Headache Pain"},{"issue":"6","key":"1224_CR76","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1046\/j.1468-2982.1993.1306410.x","volume":"13","author":"R Hering","year":"1993","unstructured":"Hering R, Glover V, Pattichis K, Catarci T, Steiner TJ (1993) 5HT in migraine patients with medication-induced headache. Cephalalgia 13(6):410\u2013412. https:\/\/doi.org\/10.1046\/j.1468-2982.1993.1306410.x","journal-title":"Cephalalgia"},{"key":"1224_CR77","doi-asserted-by":"publisher","unstructured":"Srikiatkhachorn A, Anthony M (1996) Platelet serotonin in patients with analgesic-induced headache. Cephalalgia 16(6):423\u2013426. https:\/\/doi.org\/10.1046\/j.1468-2982.1996.1606423.x","DOI":"10.1046\/j.1468-2982.1996.1606423.x"},{"issue":"7","key":"1224_CR78","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1046\/j.1526-4610.1998.3807534.x","volume":"38","author":"A Srikiatkhachorn","year":"1998","unstructured":"Srikiatkhachorn A, Puangniyom S, Govitrapong P (1998) Plasticity of 5-HT serotonin receptor in patients with analgesic-induced transformed migraine. Headache 38(7):534\u2013539. https:\/\/doi.org\/10.1046\/j.1526-4610.1998.3807534.x","journal-title":"Headache"},{"issue":"5","key":"1224_CR79","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1526-4610.2000.00052.x","volume":"40","author":"A Srikiatkhachorn","year":"2000","unstructured":"Srikiatkhachorn A, Tarasub N, Govitrapong P (2000) Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache. Headache 40(5):343\u2013350. https:\/\/doi.org\/10.1046\/j.1526-4610.2000.00052.x","journal-title":"Headache"},{"issue":"2","key":"1224_CR80","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1526-4610.2009.01591.x","volume":"50","author":"W Supornsilpchai","year":"2010","unstructured":"Supornsilpchai W, le Grand SM, Srikiatkhachorn A (2010) Involvement of pro-nociceptive 5-HT2A receptor in the pathogenesis of medication-overuse headache. Headache 50(2):185\u2013197. https:\/\/doi.org\/10.1111\/j.1526-4610.2009.01591.x","journal-title":"Headache"},{"issue":"1","key":"1224_CR81","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/art.38191","volume":"66","author":"ML Loggia","year":"2014","unstructured":"Loggia ML, Berna C, Kim J, Cahalan CM, Gollub RL, Wasan AD, Harris RE, Edwards RR, Napadow V (2014) Disrupted brain circuitry for pain-related reward\/punishment in fibromyalgia. Arthritis Rheumatol 66(1):203\u2013212. https:\/\/doi.org\/10.1002\/art.38191","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"1224_CR82","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1111\/j.1460-9568.2007.05623.x","volume":"25","author":"PB Wood","year":"2007","unstructured":"Wood PB, Schweinhardt P, Jaeger E, Dagher A, Hakyemez H, Rabiner EA, Bushnell MC, Chizh BA (2007) Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci 25(12):3576\u20133582. https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05623.x","journal-title":"Eur J Neurosci"},{"issue":"6","key":"1224_CR83","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1526-4610.1980.hed2006294.x","volume":"20","author":"B Anselmi","year":"1980","unstructured":"Anselmi B, Baldi E, Casacci F, Salmon S (1980) Endogenous opioids in cerebrospinal fluid and blood in idiopathic headache sufferers. Headache 20(6):294\u2013299. https:\/\/doi.org\/10.1111\/j.1526-4610.1980.hed2006294.x","journal-title":"Headache"},{"issue":"1","key":"1224_CR84","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.neuron.2010.03.002","volume":"66","author":"MN Baliki","year":"2010","unstructured":"Baliki MN, Geha PY, Fields HL, Apkarian AV (2010) Predicting value of pain and analgesia: nucleus accumbens response to noxious stimuli changes in the presence of chronic pain. Neuron 66(1):149\u2013160. https:\/\/doi.org\/10.1016\/j.neuron.2010.03.002","journal-title":"Neuron"},{"issue":"4","key":"1224_CR85","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.pain.2012.01.002","volume":"153","author":"JM Jarcho","year":"2012","unstructured":"Jarcho JM, Mayer EA, Jiang ZK, Feier NA, London ED (2012) Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction. Pain 153(4):744\u2013754. https:\/\/doi.org\/10.1016\/j.pain.2012.01.002","journal-title":"Pain"},{"issue":"8","key":"1224_CR86","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s10072-019-03865-9","volume":"40","author":"P Barbanti","year":"2019","unstructured":"Barbanti P, Guadagni F, de Marchis ML, Ialongo C, Egeo G, Fofi L, Aurilia C, Lovero D, Della-Morte D, Ferroni P, Palmirotta R (2019) Dopamine-beta-hydroxylase 19-bp insertion\/deletion polymorphism affects medication overuse in patients with chronic migraine. Neurol Sci 40(8):1717\u20131724. https:\/\/doi.org\/10.1007\/s10072-019-03865-9","journal-title":"Neurol Sci"},{"issue":"5","key":"1224_CR87","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/head.12559","volume":"55","author":"S Cargnin","year":"2015","unstructured":"Cargnin S, Pautasso C, Viana M, Sances G, Mittino D, Cantello R, Tassorelli C, Nappi G, Terrazzino S (2015) Association of RAMP1 rs7590387 with the risk of migraine transformation into medication overuse headache. Headache 55(5):658\u2013668. https:\/\/doi.org\/10.1111\/head.12559","journal-title":"Headache"},{"issue":"5335","key":"1224_CR88","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1126\/science.278.5335.52","volume":"278","author":"GF Koob","year":"1997","unstructured":"Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278(5335):52\u201358. https:\/\/doi.org\/10.1126\/science.278.5335.52","journal-title":"Science"},{"issue":"2","key":"1224_CR89","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","volume":"24","author":"GF Koob","year":"2001","unstructured":"Koob GF, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24(2):97\u2013129. https:\/\/doi.org\/10.1016\/S0893-133X(00)00195-0","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"1224_CR90","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/026988119901300406","volume":"13","author":"ND Volkow","year":"1999","unstructured":"Volkow ND, Fowler JS, Wang GJ (1999) Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. J Psychopharmacol 13(4):337\u2013345. https:\/\/doi.org\/10.1177\/026988119901300406","journal-title":"J Psychopharmacol"},{"issue":"3","key":"1224_CR91","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/00008571-199506000-00001","volume":"5","author":"K Blum","year":"1995","unstructured":"Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJH, Comings DE (1995) Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. Pharmacogenet Genomics 5(3):121\u2013141. https:\/\/doi.org\/10.1097\/00008571-199506000-00001","journal-title":"Pharmacogenet Genomics"},{"key":"1224_CR92","doi-asserted-by":"publisher","unstructured":"Clarke, T.-K., et al., The Dopamine Receptor D2 (DRD2) SNP rs1076560 is Associated with Opioid Addiction. Annals of Human Genetics, 2014. 78(1): p. 33\u201339 DOI: https:\/\/doi.org\/10.1111\/ahg.12046","DOI":"10.1111\/ahg.12046"},{"key":"1224_CR93","doi-asserted-by":"publisher","unstructured":"Groman, S.M. and J.D. Jentsch, Cognitive control and the dopamine D2-like receptor: a dimensional understanding of addiction. Depression Anxiety, 2012. 29(4): p. 295\u2013306 DOI: https:\/\/doi.org\/https:\/\/doi.org\/10.1002\/da.20897","DOI":"10.1002\/da.20897"},{"issue":"3","key":"1224_CR94","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/1096-8628(20000612)96:3<331::aid-ajmg19>3.0.co;2-0","volume":"96","author":"AF Jorm","year":"2000","unstructured":"Jorm AF, Henderson AS, Jacomb PA, Christensen H, Korten AE, Rodgers B, Tan X, Easteal S (2000) Association of smoking and personality with a polymorphism of the dopamine transporter gene: results from a community survey. Am J Med Genet 96(3):331\u2013334. https:\/\/doi.org\/10.1002\/1096-8628(20000612)96:3<331::aid-ajmg19>3.0.co;2-0","journal-title":"Am J Med Genet"},{"issue":"4","key":"1224_CR95","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1300\/j069v20n04_08","volume":"20","author":"TP Laine","year":"2001","unstructured":"Laine TP, Ahonen A, R\u00e4s\u00e4nen P, Tiihonen J (2001) Dopamine transporter density and novelty seeking among alcoholics. J Addict Dis 20(4):91\u201396. https:\/\/doi.org\/10.1300\/j069v20n04_08","journal-title":"J Addict Dis"},{"issue":"1","key":"1224_CR96","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1037\/0278-6133.18.1.14","volume":"18","author":"C Lerman","year":"1999","unstructured":"Lerman C, Caporaso NE, Audrain J, Main D, Bowman ED, Lockshin B, Boyd NR, Shields PG (1999) Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol 18(1):14\u201320. https:\/\/doi.org\/10.1037\/0278-6133.18.1.14","journal-title":"Health Psychol"},{"issue":"4","key":"1224_CR97","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1176\/ajp.155.4.474","volume":"155","author":"LG Schmidt","year":"1998","unstructured":"Schmidt LG, Harms H, Kuhn S, Rommelspacher H, Sander T (1998) Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene. Am J Psychiatry 155(4):474\u2013478. https:\/\/doi.org\/10.1176\/ajp.155.4.474","journal-title":"Am J Psychiatry"},{"key":"1224_CR98","doi-asserted-by":"publisher","unstructured":"Ferraro, S., et al., In Medication-Overuse Headache, fMRI Shows Long-Lasting Dysfunction in Midbrain Areas. Headache, 2012. 52(10): p. 1520\u20131534 DOI: https:\/\/doi.org\/https:\/\/doi.org\/10.1111\/j.1526-4610.2012.02276.x","DOI":"10.1111\/j.1526-4610.2012.02276.x"},{"issue":"7","key":"1224_CR99","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3109\/15622975.2012.665175","volume":"13","author":"F Riederer","year":"2012","unstructured":"Riederer F, Marti M, Luechinger R, Lanzenberger R, von Meyenburg J, Gantenbein AR, Pirrotta R, Gaul C, Kollias S, S\u00e1ndor PS (2012) Grey matter changes associated with medication-overuse headache: correlations with disease related disability and anxiety. World J Biol Psychiatry 13(7):517\u2013525. https:\/\/doi.org\/10.3109\/15622975.2012.665175","journal-title":"World J Biol Psychiatry"},{"issue":"14","key":"1224_CR100","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1177\/0333102416630593","volume":"36","author":"TH Lai","year":"2016","unstructured":"Lai TH, Chou KH, Fuh JL, Lee PL, Kung YC, Lin CP, Wang SJ (2016) Gray matter changes related to medication overuse in patients with chronic migraine. Cephalalgia 36(14):1324\u20131333. https:\/\/doi.org\/10.1177\/0333102416630593","journal-title":"Cephalalgia"},{"issue":"4","key":"1224_CR101","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1177\/0271678X17740794","volume":"39","author":"CD Chong","year":"2019","unstructured":"Chong CD, Schwedt TJ, Hougaard A (2019) Brain functional connectivity in headache disorders: a narrative review of MRI investigations. J Cereb Blood Flow Metab 39(4):650\u2013669. https:\/\/doi.org\/10.1177\/0271678X17740794","journal-title":"J Cereb Blood Flow Metab"},{"issue":"Pt 2","key":"1224_CR102","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/brain\/awh691","volume":"129","author":"A Fumal","year":"2006","unstructured":"Fumal A, Laureys S, di Clemente L, Boly M, Bohotin V, Vandenheede M, Coppola G, Salmon E, Kupers R, Schoenen J (2006) Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 129(Pt 2):543\u2013550. https:\/\/doi.org\/10.1093\/brain\/awh691","journal-title":"Brain"},{"issue":"2","key":"1224_CR103","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/0333102417737779","volume":"38","author":"LN Carlsen","year":"2018","unstructured":"Carlsen LN, Munksgaard SB, Jensen RH, Bendtsen L (2018) Complete detoxification is the most effective treatment of medication-overuse headache: a randomized controlled open-label trial. Cephalalgia 38(2):225\u2013236. https:\/\/doi.org\/10.1177\/0333102417737779","journal-title":"Cephalalgia"},{"issue":"6","key":"1224_CR104","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/ejp.1383","volume":"23","author":"IMS Engelstoft","year":"2019","unstructured":"Engelstoft IMS, Carlsen LN, Munksgaard SB, Nielsen M, Jensen RH, Bendtsen L (2019) Complete withdrawal is the most feasible treatment for medication-overuse headache: a randomized controlled open-label trial. Eur J Pain 23(6):1162\u20131170. https:\/\/doi.org\/10.1002\/ejp.1383","journal-title":"Eur J Pain"},{"issue":"9","key":"1224_CR105","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1468-1331.2011.03497.x","volume":"18","author":"S Evers","year":"2011","unstructured":"Evers S, Jensen R, S. European Federation Of neurological (2011) Treatment of medication overuse headache--guideline of the EFNS headache panel. Eur J Neurol 18(9):1115\u20131121. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03497.x","journal-title":"Eur J Neurol"},{"issue":"6","key":"1224_CR106","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jpain.2016.12.005","volume":"18","author":"MJ de Goffau","year":"2017","unstructured":"de Goffau MJ, Klaver ARE, Willemsen MG, Bindels PJE, Verhagen AP (2017) The effectiveness of treatments for patients with medication overuse headache: a systematic review and meta-analysis. J Pain 18(6):615\u2013627. https:\/\/doi.org\/10.1016\/j.jpain.2016.12.005","journal-title":"J Pain"},{"issue":"7","key":"1224_CR107","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/ene.14268","volume":"27","author":"HC Diener","year":"2020","unstructured":"Diener HC, Antonaci F, Braschinsky M, Evers S, Jensen R, Lainez M, Kristoffersen ES, Tassorelli C, Ryliskiene K, Petersen JA (2020) European academy of neurology guideline on the management of medication-overuse headache. Eur J Neurol 27(7):1102\u20131116. https:\/\/doi.org\/10.1111\/ene.14268","journal-title":"Eur J Neurol"},{"issue":"1","key":"1224_CR108","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s10194-019-1000-5","volume":"20","author":"C Tiseo","year":"2019","unstructured":"Tiseo C, Ornello R, Pistoia F, Sacco S (2019) How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice. J Headache Pain 20(1):49. https:\/\/doi.org\/10.1186\/s10194-019-1000-5","journal-title":"J Headache Pain"},{"issue":"20","key":"1224_CR109","doi-asserted-by":"publisher","first-page":"e2309","DOI":"10.1212\/WNL.0000000000007497","volume":"92","author":"SJ Tepper","year":"2019","unstructured":"Tepper SJ, Diener HC, Ashina M, Brandes JL, Friedman DI, Reuter U, Cheng S, Nilsen J, Leonardi DK, Lenz RA, Mikol DD (2019) Erenumab in chronic migraine with medication overuse: subgroup analysis of a randomized trial. Neurology 92(20):e2309\u2013e2320. https:\/\/doi.org\/10.1212\/WNL.0000000000007497","journal-title":"Neurology"},{"key":"1224_CR110","doi-asserted-by":"publisher","unstructured":"Dodick DW, Doty EG, Aurora SK, Ruff DD, Stauffer VL, Jedynak J, Dong Y, Pearlman EM (2020) Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine. Cephalalgia:333102420966658. https:\/\/doi.org\/10.1177\/0333102420966658","DOI":"10.1177\/0333102420966658"},{"issue":"1","key":"1224_CR111","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s10194-020-01173-8","volume":"21","author":"SD Silberstein","year":"2020","unstructured":"Silberstein SD, Cohen JM, Seminerio MJ, Yang R, Ashina S, Katsarava Z (2020) The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study. J Headache Pain 21(1):114. https:\/\/doi.org\/10.1186\/s10194-020-01173-8","journal-title":"J Headache Pain"},{"issue":"5","key":"1224_CR112","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/brain\/awz052","volume":"142","author":"JA Pijpers","year":"2019","unstructured":"Pijpers JA, Kies DA, Louter MA, van Zwet EW, Ferrari MD, Terwindt GM (2019) Acute withdrawal and botulinum toxin a in chronic migraine with medication overuse: a double-blind randomized controlled trial. Brain 142(5):1203\u20131214. https:\/\/doi.org\/10.1093\/brain\/awz052","journal-title":"Brain"},{"issue":"2","key":"1224_CR113","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1468-2982.2008.01711.x","volume":"29","author":"K Hagen","year":"2009","unstructured":"Hagen K, Albretsen C, Vilming ST, Salvesen R, Gr\u00f8ning M, Helde G, Gravdahl G, Zwart JA, Stovner LJ (2009) Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia 29(2):221\u2013232. https:\/\/doi.org\/10.1111\/j.1468-2982.2008.01711.x","journal-title":"Cephalalgia"},{"issue":"9","key":"1224_CR114","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11940-017-0465-2","volume":"19","author":"A Negro","year":"2017","unstructured":"Negro A, Curto M, Lionetto L, Guerzoni S, Pini LA, Martelletti P (2017) A critical evaluation on MOH current treatments. Curr Treat Options Neurol 19(9):32. https:\/\/doi.org\/10.1007\/s11940-017-0465-2","journal-title":"Curr Treat Options Neurol"},{"issue":"Suppl 1","key":"1224_CR115","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1007\/s10072-011-0553-0","volume":"32","author":"L Grazzi","year":"2011","unstructured":"Grazzi L, Bussone G (2011) What future for treatment of chronic migraine with medication overuse? Neurol Sci 32(Suppl 1):S19\u2013S22. https:\/\/doi.org\/10.1007\/s10072-011-0553-0","journal-title":"Neurol Sci"},{"issue":"6","key":"1224_CR116","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1046\/j.1526-4610.2002.02123.x","volume":"42","author":"L Grazzi","year":"2002","unstructured":"Grazzi L, Andrasik F, D'Amico D, Leone M, Usai S, Kass SJ, Bussone G (2002) Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache 42(6):483\u2013490. https:\/\/doi.org\/10.1046\/j.1526-4610.2002.02123.x","journal-title":"Headache"},{"issue":"3","key":"1224_CR117","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11916-009-0041-x","volume":"13","author":"F Andrasik","year":"2009","unstructured":"Andrasik F, Buse DC, Grazzi L (2009) Behavioral medicine for migraine and medication overuse headache. Curr Pain Headache Rep 13(3):241\u2013248. https:\/\/doi.org\/10.1007\/s11916-009-0041-x","journal-title":"Curr Pain Headache Rep"},{"issue":"6","key":"1224_CR118","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10072-009-0131-x","volume":"30","author":"E Sancisi","year":"2009","unstructured":"Sancisi E, Rausa M, Zanigni S, Cevoli S, Pala AN, Nicodemo M, Grimaldi D, Montagna P, Cortelli P, Pierangeli G (2009) Self-help group and medication overuse headache: preliminary data. Neurol Sci 30(6):459\u2013463. https:\/\/doi.org\/10.1007\/s10072-009-0131-x","journal-title":"Neurol Sci"},{"issue":"1","key":"1224_CR119","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1129-2377-14-59","volume":"14","author":"F Radat","year":"2013","unstructured":"Radat F, Chanraud S, di Scala G, Dousset V, Allard M (2013) Psychological and neuropsychological correlates of dependence-related behaviour in medication overuse headaches: a one year follow-up study. J Headache Pain 14(1):59. https:\/\/doi.org\/10.1186\/1129-2377-14-59","journal-title":"J Headache Pain"},{"issue":"8","key":"1224_CR120","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1176\/appi.ajp.2018.17101174","volume":"175","author":"ND Volkow","year":"2018","unstructured":"Volkow ND, Boyle M (2018) Neuroscience of addiction: relevance to prevention and treatment. Am J Psychiatry 175(8):729\u2013740. https:\/\/doi.org\/10.1176\/appi.ajp.2018.17101174","journal-title":"Am J Psychiatry"}],"updated-by":[{"DOI":"10.1186\/s10194-021-01275-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000}}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-021-01224-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-021-01224-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-021-01224-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T02:03:08Z","timestamp":1625536988000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-021-01224-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":120,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1224"],"URL":"https:\/\/doi.org\/10.1186\/s10194-021-01224-8","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,28]]},"assertion":[{"value":"22 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s10194-021-01275-x","URL":"https:\/\/doi.org\/10.1186\/s10194-021-01275-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}